Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe …
D Blaise, M Kuentz, C Fortanier, JH Bourhis… - Journal of Clinical …, 2000 - ascopubs.org
PURPOSE: To compare hematologic recovery in patients receiving allogeneic blood cell
transplantation (BCT) with those receiving allogeneic bone marrow transplantation (BMT) …
transplantation (BCT) with those receiving allogeneic bone marrow transplantation (BMT) …
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a …
N Schmitz, A Bacigalupo, D Hasenclever… - Bone marrow …, 1998 - nature.com
In a multicentre trial involving 20 transplant centres from 10 countries haematopoietic stem
cells were obtained either from the bone marrow of 33 sibling donors or from the peripheral …
cells were obtained either from the bone marrow of 33 sibling donors or from the peripheral …
Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow …
Michallet, Tanguy, Socié, Thiébaut… - British journal of …, 2000 - Wiley Online Library
Although recurrent malignancy is the most frequent indication for second stem cell
transplantation (2nd SCT), there are few reports that include sufficiently large numbers of …
transplantation (2nd SCT), there are few reports that include sufficiently large numbers of …
Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the …
N Schmitz, M Eapen, MM Horowitz, MJ Zhang, JP Klein… - Blood, 2006 - ashpublications.org
We previously compared outcomes after allogeneic peripheral-blood stem cell (PBSC) and
bone marrow (BM) transplantation in 706 patients with leukemia. We obtained long-term …
bone marrow (BM) transplantation in 706 patients with leukemia. We obtained long-term …
Autologous bone marrow transplantation for acute leukaemia in remission
NC Gorin, P Herve, P Aegerter… - British journal of …, 1986 - Wiley Online Library
Between 1980 and 1985, 175 patients with acute leukaemia in first or subsequent complete
remission (CR) were treated by chemotherapy or chemoradiotherapy followed by …
remission (CR) were treated by chemotherapy or chemoradiotherapy followed by …
Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation
A Bosi, D Laszlo, M Labopin, J Reffeirs… - Journal of clinical …, 2001 - ascopubs.org
PURPOSE: Leukemic relapse is the most frequent cause of treatment failure after allogeneic
hematopoietic stem-cell transplantation (HSCT). To identify prognostic factors affecting the …
hematopoietic stem-cell transplantation (HSCT). To identify prognostic factors affecting the …
Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies.
R Champlin, RP Gale - Seminars in hematology, 1987 - europepmc.org
Bone marrow transplantation is an effective therapy in patients with acute leukemia. High-
dose chemotherapy with or without total body irradiation and allogeneic bone marrow …
dose chemotherapy with or without total body irradiation and allogeneic bone marrow …
Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial
R Powles, J Mehta, S Kulkarni, J Treleaven, B Millar… - The Lancet, 2000 - thelancet.com
Background Atologous transplantation with peripheral blood stem cells (PBSC) results in
faster haematopoietic-cell repopulation than with bone marrow. We prospectively compared …
faster haematopoietic-cell repopulation than with bone marrow. We prospectively compared …
Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia
N Schmitz, M Beksac, D Hasenclever… - Blood, The Journal …, 2002 - ashpublications.org
Allogeneic mobilized peripheral blood progenitor cells instead of bone marrow are
increasingly used to restore hematopoiesis after myeloablative therapy. Data supporting this …
increasingly used to restore hematopoiesis after myeloablative therapy. Data supporting this …
Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia
M Korbling, W Hunstein, TM Fliedner, S Cayeux… - 1989 - ashpublications.org
Autologous bone marrow transplantation (ABMT) makes it possible to escalate the dose of
cytotoxic treatment to a lethal range. Disease-free survival (DFS) following myeloablative …
cytotoxic treatment to a lethal range. Disease-free survival (DFS) following myeloablative …